Literature DB >> 22247586

Robust thermoregulatory overcompensation, rather than tolerance, develops with serial administrations of 70% nitrous oxide to rats.

Karl J Kaiyala1, Ben Chan, Douglas S Ramsay.   

Abstract

Changes in typical whole-animal dependent variables following drug administration represent an integral of the drug's pharmacological effect, the individual's autonomic and behavioral responses to the resulting disturbance, and many other influences. An archetypical example is core temperature (T(c)), long used for quantifying initial drug sensitivity and tolerance acquisition over repeated drug administrations. Our previous work suggested that rats differing in initial sensitivity to nitrous oxide (N(2)O)-induced hypothermia would exhibit different patterns of tolerance development across N(2)O administrations. Specifically, we hypothesized that rats with an initially insensitive phenotype would subsequently develop regulatory overcompensation that would mediate an allostatic hyperthermic state, whereas rats with an initially sensitive phenotype would subsequently compensate to a homeostatic normothermic state. To preclude confounding due to handling and invasive procedures, a valid test of this prediction required non-invasive thermal measurements via implanted telemetric temperature sensors, combined direct and indirect calorimetry, and automated drug delivery to enable repeatable steady-state dosing. We screened 237 adult rats for initial sensitivity to 70% N(2)O-induced hypothermia. Thirty highly sensitive rats that exhibited marked hypothermia when screened and 30 highly insensitive rats that initially exhibited minimal hypothermia were randomized to three groups (n=10 each/group) that received: 1) twelve 90-min exposures to 70% N(2)O using a classical conditioning procedure, 2) twelve 90-min exposures to 70% N(2)O using a random control procedure for conditioning, or 3) a no-drug control group that received custom-made air. Metabolic heat production (via indirect calorimetry), body heat loss (via direct calorimetry) and T(c) (via telemetry) were simultaneously quantified during N(2)O and control gas administrations. Initially insensitive rats rapidly acquired (3(rd) administration) a significant allostatic hyperthermic phenotype during N(2)O administration whereas initially sensitive rats exhibited classical tolerance (normothermia) during N(2)O inhalation in the 4(th) and 5(th) sessions. However, the sensitive rats subsequently acquired the hyperthermic phenotype and became indistinguishable from initially insensitive rats during the 11(th) and 12th N(2)O administrations. The major mechanism for hyperthermia was a brisk increase in metabolic heat production. However, we obtained no evidence for classical conditioning of thermal responses. We conclude that the degree of initial sensitivity to N(2)O-induced hypothermia predicts the temporal pattern of thermal adaptation over repeated N(2)O administrations, but that initially insensitive and sensitive animals eventually converge to similar (and substantial) magnitudes of within-administration hyperthermia mediated by hyper-compensatory heat production.

Entities:  

Year:  2012        PMID: 22247586      PMCID: PMC3255088          DOI: 10.1016/j.jtherbio.2011.10.004

Source DB:  PubMed          Journal:  J Therm Biol        ISSN: 0306-4565            Impact factor:   2.902


  25 in total

1.  Drug anticipation and drug addiction. The 1998 H. David Archibald Lecture.

Authors:  S Siegel
Journal:  Addiction       Date:  1999-08       Impact factor: 6.526

Review 2.  Reverse engineering of biological complexity.

Authors:  Marie E Csete; John C Doyle
Journal:  Science       Date:  2002-03-01       Impact factor: 47.728

3.  Nitrous oxide causes a regulated hypothermia: rats select a cooler ambient temperature while becoming hypothermic.

Authors:  Douglas S Ramsay; Jana Seaman; Karl J Kaiyala
Journal:  Physiol Behav       Date:  2010-12-22

Review 4.  Addiction and the brain antireward system.

Authors:  George F Koob; Michel Le Moal
Journal:  Annu Rev Psychol       Date:  2008       Impact factor: 24.137

Review 5.  System properties, feedback control and effector coordination of human temperature regulation.

Authors:  Jürgen Werner
Journal:  Eur J Appl Physiol       Date:  2009-09-29       Impact factor: 3.078

Review 6.  Multiple thermoregulatory effectors with independent central controls.

Authors:  Robin M McAllen; Mutsumi Tanaka; Yoichiro Ootsuka; Michael J McKinley
Journal:  Eur J Appl Physiol       Date:  2009-12-01       Impact factor: 3.078

7.  Individual differences in initial sensitivity and acute tolerance predict patterns of chronic drug tolerance to nitrous-oxide-induced hypothermia in rats.

Authors:  Douglas S Ramsay; Karl J Kaiyala; Brian G Leroux; Stephen C Woods
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

Review 8.  Metabolic syndrome and robustness tradeoffs.

Authors:  Hiroaki Kitano; Kanae Oda; Tomomi Kimura; Yukiko Matsuoka; Marie Csete; John Doyle; Masaaki Muramatsu
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

9.  Assessment of heat production, heat loss, and core temperature during nitrous oxide exposure: a new paradigm for studying drug effects and opponent responses.

Authors:  Karl J Kaiyala; Douglas S Ramsay
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-11-24       Impact factor: 3.619

10.  Nitrous oxide (N2O) prevents latent pain sensitization and long-term anxiety-like behavior in pain and opioid-experienced rats.

Authors:  Baptiste Bessière; Philippe Richebé; Emilie Laboureyras; Jean-Paul Laulin; Angelo Contarino; Guy Simonnet
Journal:  Neuropharmacology       Date:  2007-08-14       Impact factor: 5.250

View more
  9 in total

1.  Clarifying the roles of homeostasis and allostasis in physiological regulation.

Authors:  Douglas S Ramsay; Stephen C Woods
Journal:  Psychol Rev       Date:  2014-04       Impact factor: 8.934

2.  Brown adipose tissue thermogenesis does not explain the intra-administration hyperthermic sign-reversal induced by serial administrations of 60% nitrous oxide to rats.

Authors:  Salwa Al-Noori; Douglas S Ramsay; Andreas Cimpan; Zoe Maltzer; Jessie Zou; Karl J Kaiyala
Journal:  J Therm Biol       Date:  2016-07-20       Impact factor: 2.902

3.  Repeated nitrous oxide exposure in rats causes a thermoregulatory sign-reversal with concurrent activation of opposing thermoregulatory effectors.

Authors:  Douglas S Ramsay; Stephen C Woods; Karl J Kaiyala
Journal:  Temperature (Austin)       Date:  2014 Oct-Dec

4.  Predicting addictive vulnerability: individual differences in initial responding to a drug's pharmacological effects.

Authors:  Douglas S Ramsay; Salwa Al-Noori; Jason Shao; Brian G Leroux; Stephen C Woods; Karl J Kaiyala
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

5.  Drug-induced regulatory overcompensation has motivational consequences: Implications for homeostatic and allostatic models of drug addiction.

Authors:  Douglas S Ramsay; Stephen C Woods; Karl J Kaiyala
Journal:  Temperature (Austin)       Date:  2014

6.  Persistence of a hyperthermic sign-reversal during nitrous oxide inhalation despite cue-exposure treatment with and without a drug-onset cue.

Authors:  Karl J Kaiyala; Stephen C Woods; Douglas S Ramsay
Journal:  Temperature (Austin)       Date:  2014 Oct-Dec

7.  Concentration-related metabolic rate and behavioral thermoregulatory adaptations to serial administrations of nitrous oxide in rats.

Authors:  Karl J Kaiyala; Douglas S Ramsay
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

8.  Correctly identifying responses is critical for understanding homeostatic and allostatic regulation.

Authors:  Douglas S Ramsay; Karl J Kaiyala; Stephen C Woods
Journal:  Temperature (Austin)       Date:  2014-12-31

9.  Validation of an equation for energy expenditure that does not require the respiratory quotient.

Authors:  Karl J Kaiyala; Brent E Wisse; John R B Lighton
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.